- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/06 - Antimalarials
Patent holdings for IPC class A61P 33/06
Total number of patents in this class: 1151
10-year publication summary
37
|
44
|
47
|
50
|
69
|
68
|
87
|
77
|
57
|
24
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mmv Medicines for Malaria Venture | 31 |
21 |
The Walter and Eliza Hall Institute of Medical Research | 170 |
21 |
Centre National de La Recherche Scientifique | 9632 |
20 |
Novartis AG | 11238 |
18 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
18 |
Glaxosmithkline Intellectual Property Development Limited | 723 |
12 |
Glaxo Group Limited | 4496 |
11 |
The Regents of the University of California | 18943 |
11 |
Merck Patent GmbH | 5909 |
11 |
The Johns Hopkins University | 5377 |
11 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
10 |
Institut Pasteur | 798 |
10 |
MSD R & D (China) Co. LTD. | 50 |
10 |
Centre National de La Recherche Scientifique (cnrs) | 3191 |
10 |
The Broad Institute, Inc. | 1584 |
8 |
University of Washington | 2157 |
8 |
UCB Biopharma SRL | 626 |
8 |
Merck Sharp & Dohme Corp. | 2247 |
7 |
The United States of America as represented by the Secretary of the Army | 1195 |
7 |
Griffith University | 143 |
7 |
Other owners | 912 |